PCL

PCL, Inc. is a company operating in the fields of COVID-19 testing, serology, healthcare, research and development, medical devices, and in-vitro diagnostics (IVD). The company is located in Seoul, South Korea and was founded on December 2, 2008. The company is legally known as PCL, Inc. and operates as a joint-stock company. PCL is currently active and employs between 50 and 99 people.

The company's headquarters are situated in Geumcheon District and it has additional locations in Songpa District and Geumcheon District in Seoul. Its full addresses are Floor 17, SK V1 metrocity building B, 128, Beobwon-ro, Songpa-gu, Seoul, 08510, Republic of Korea, and Rm 701, Star Valley, 99, Digital-ro 9-gil, Geumcheon-gu, Seoul, 08510, Republic of Korea.

PCL is traded on the KOSDAQ stock exchange, which is a part of the Korea Exchange. The company's stock symbol is 241820. PCL operates as an organization engaged in research in various fields of healthcare and diagnostics.